Antimalarial drugs can make cancer treatment effective

One study found that antimalarial drugs such as chloroquine and hydroxychloroquine may make cancer treatment more effective.

Researchers from Repurposing Drugs in Oncology (ReDO) say there is evidence to include these drugs in the next clinical investigation.

The authors are particularly excited about the potential of chloroquine and hydroxychloroquine because of evidence that tumor cells are more sensitive to this drug in the treatment of cancer.

Ciska Verbaanderd, author Ciska Verbaanderd, said: "Surprisingly, chloroquine and hydroxychloroquine have these diverse mechanisms of action," said Ciska Verbaanderd. This study has led to a deep understanding of tumor science, as well as the importance of spontaneous tumor and immune system as well as multiple effects of many drugs. "

Verbaanderd continues to show that these antimalarial drugs can bring significant clinical benefits to certain cancer patients, especially when combined with standard anti-cancer therapies. This should be confirmed by additional clinical results.

One of the authors Vikas P. Sukhatme added: "We expect more for the results of 30 upcoming clinical studies that will continuously use chloroquine or hydroxychloroquine to treat cancer that is about to be published in time. next."

The hope of the researchers and these experiments will contribute to increasing awareness about the value of medicine of drugs, methods, potential applications, medications that treat many diseases with cancer strains.

See more:

1. New cancer drugs can also prevent cat allergies
2. More than half of new cancer drugs may not work, studies show